African Journal of Primary Health Care & Family Medicine · 2020 · 22 citations · 14 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceInfectious Disease EpidemiologyMedical MicrobiologyAntibiotic ResistanceAntimicrobial Susceptibility TestingBacterial EpidemiologyAntibiotic Susceptibility TestingBiochemical Identification TestsBiochemical Resistance TestsDrug Resistance Pattern AnalysisDrug Susceptibility AssaysGeographical Distribution AnalysisPhenotypic Susceptibility ProfilingSerotype Distribution
BACKGROUND: Multiple drug resistance has become a major threat to the treatment of cholera. Recent studies in Kenya have described the epidemiology, especially the risk factors, of cholera; however, there is little information on the phenotypic and drug susceptibility patterns of Vibrio cholerae (V. cholerae) in outbreaks that in the recent past have occurred in western Kenya. AIM: To characterise and determine the antibiotics' susceptibility profiling of toxigenic V. cholerae isolates from Kisumu County. SETTING: The project was conducted in Kisumu County, Kenya. METHODS: A total of 119 V. cholerae O1, biotype El Tor, isolates collected during 2017 cholera outbreak in Kisumu County were used for this study. The samples were cultured on thiosulphate-citrate-bile salts sucrose (TCBS) agar and biochemical tests were carried out using standard procedures. Susceptibility tests were conducted by using various conventional antibiotics against standard procedures. RESULTS: Of the 119 isolates, 101 were confirmed to be V. cholerae belonging to serotypes Inaba and Ogawa, with Inaba being the predominant serotype (73.95%). The isolates were susceptible to ciprofloxacin (100%), ofloxacin (100%), gentamycin (100%), doxycycline (99%), ceftriaxone (99%) and streptomycin (96.04%) antimicrobials, and resistant to erythromycin (53.47%), amoxicillin (64.4%), nalidixic acid (83.2%) and ampicillin (89.11%), with high resistance to cotrimoxazole (99%) and tetracycline (97%). CONCLUSION: Vibrio cholerae was resistant to multiple antibiotics, including those commonly used in the management of cholera. Taken together, there is a need to carry out regular surveillance on antimicrobial drug resistance during outbreaks.
14
Masaaki Iwanaga, Claudia Toma, Tomoko Miyazato et al. · Antimicrobial Agents and Chemotherapy · 2004 · 126 citations · Full text
Anders Dalsgaard, Anita Forslund, Andreas Petersen et al. · Journal of Clinical Microbiology · 2000 · 82 citations · Full text
Magdalena Wiesner, Mussaret B. Zaidi, Edmundo Calva et al. · BMC Microbiology · 2009 · 68 citations · Full text